Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel

Summary

The purpose of this trial is to assess the effect of immunotherapy with the bacterial preparation MV130 on the spread and course of SARS-CoV-2 infection in highly exposed subjets, as is the case with healthcare personnel.

Timeline

Start

2020-10

Primary completion

2021-12

Completion

2021-12

Outcome

Outcome not reported

Stopped: “Not authorized by Cofepris (Mexico Competent Regulatory Authority)”

Drugs

Indications